Acciones Innovus Pharmaceuticals Inc Other OTC
Acciones
US45778V1061
Farmacéuticos
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+33,97 % | 693 mil M | |
+29,39 % | 584 mil M | |
-2,87 % | 372 mil M | |
+20,57 % | 332 mil M | |
+6,96 % | 294 mil M | |
+14,09 % | 239 mil M | |
-3,03 % | 211 mil M | |
+10,02 % | 210 mil M | |
+9,13 % | 168 mil M |